Physician profile
Patrick R Mcdonald
NPI 1548423031
$1,960.25
in general payments reported to CMS, 2019-2025
14 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $199 · 2021: $236 · 2022: $739 · 2023: $195 · 2024: $75.44 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $371.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $758.27 | 2019-2023 | Citrefix, Allopure, Allomatrix |
| Kerecis Limited | $237.19 | 2022 | |
| Organogenesis INC. | $201.05 | 2020-2025 | Affinity, Puraply, Nushield |
| In2bones USA, LLC | $138.38 | 2022 | |
| Novus Surgical Solutions LLC | $120.19 | 2019 | |
| Endo Pharmaceuticals INC. | $107.25 | 2019-2022 | |
| Depuy Synthes Sales INC. | $104.69 | 2019-2024 | Monovisc, Orthovisc |
| Pacira Therapeutics, INC. | $92.10 | 2019-2020 | |
| Si-Bone, INC. | $85.29 | 2019 | |
| Bioventus LLC | $52.07 | 2024-2025 | Durolane, Xcell |
| Fidia Pharma USA INC. | $22.35 | 2024 | Triluron |
| Ermi LLC | $14.29 | 2019 | |
| Djo, LLC | $14.26 | 2020 | |
| Horizon Therapeutics Plc | $12.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mcdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.